No Survival Advantage with ACE Inhibitors in Stable CAD (CME/CE)

(MedPage Today) -- Blocking RAS pathway not better than other preventive strategies
via No Survival Advantage with ACE Inhibitors in Stable CAD (CME/CE)
by